Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-02-17 @ 11:00 PM
Study NCT ID:
NCT02329769
Status:
TERMINATED
Last Update Posted:
2017-12-08
First Post:
2014-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Sponsor:
BioMarin Pharmaceutical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PRO044-CLIN-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None